Core Insights - Quantum measurement technology with ultra-high sensitivity to weak magnetic fields is playing a role in medical diagnostics, particularly in detecting early signs of diseases through subtle magnetic field changes in the human body [1][2] - The application of "quantum + medical" technology has attracted investor attention, with discussions on the integration of quantum precision measurement and medical diagnostics at the recent 2025 Quantum Technology and Industry Conference [1] Industry Overview - The domestic market for biological magnetic technology devices has begun to see clinical validation in major hospitals for diagnosing cardiovascular diseases such as myocardial ischemia and heart failure, although pricing details have not yet been disclosed [2] - The potential market for cardiovascular diseases in China is estimated to be in the hundreds of billions, with 330 million patients, including over 10 million with coronary heart disease [2] - The medical device market in China has grown from over 200 billion yuan in 2018 to nearly 400 billion yuan in 2023, with projections to exceed 600 billion yuan by 2030, indicating a significant opportunity for quantum biological magnetic technology [2] Technological Development - The development of superconducting biological magnetic technology, including devices like magnetocardiograms and magnetoencephalograms, has been in progress for 20 years and is nearing commercialization [1] - Despite the promising applications, the high cost and complexity of biological magnetic technology currently limit its use as a routine clinical examination method [3] - Future advancements in high-temperature superconducting technology and the reduction in costs of quantum sensors are expected to make magnetocardiogram devices more affordable and widely applicable in clinical settings [3]